Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.095 USD | +0.24% | -6.89% | -37.09% |
05-13 | Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating | MT |
05-09 | Transcript : Coherus BioSciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.94% | 240M | |
+4.44% | 111B | |
+10.92% | 105B | |
-12.05% | 22.34B | |
-3.81% | 21.93B | |
-5.89% | 18.59B | |
-36.52% | 18.12B | |
-9.80% | 16.96B | |
+3.30% | 13.7B | |
+37.22% | 12.45B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Sector Update: Health Care Stocks Decline with Broader Markets